1919 related articles for article (PubMed ID: 8382353)
1. Melanocyte culture lines from Tyr-SV40E transgenic mice: models for the molecular genetic evolution of malignant melanoma.
Larue L; Dougherty N; Bradl M; Mintz B
Oncogene; 1993 Mar; 8(3):523-31. PubMed ID: 8382353
[TBL] [Abstract][Full Text] [Related]
2. Genetic predisposition of transgenic mouse melanocytes to melanoma results in malignant melanoma after exposure to a low ultraviolet B intensity nontumorigenic for normal melanocytes.
Larue L; Dougherty N; Mintz B
Proc Natl Acad Sci U S A; 1992 Oct; 89(20):9534-8. PubMed ID: 1329100
[TBL] [Abstract][Full Text] [Related]
3. Ultraviolet radiation-induced malignant skin melanoma in melanoma-susceptible transgenic mice.
Klein-Szanto AJ; Silvers WK; Mintz B
Cancer Res; 1994 Sep; 54(17):4569-72. PubMed ID: 8062242
[TBL] [Abstract][Full Text] [Related]
4. A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent.
Robinson C; van Bruggen I; Segal A; Dunham M; Sherwood A; Koentgen F; Robinson BW; Lake RA
Cancer Res; 2006 Nov; 66(22):10786-94. PubMed ID: 17108115
[TBL] [Abstract][Full Text] [Related]
5. Accelerated ultraviolet radiation-induced carcinogenesis in hepatocyte growth factor/scatter factor transgenic mice.
Noonan FP; Otsuka T; Bang S; Anver MR; Merlino G
Cancer Res; 2000 Jul; 60(14):3738-43. PubMed ID: 10919643
[TBL] [Abstract][Full Text] [Related]
6. Metastatic cutaneous melanoma promoted by ultraviolet radiation in mice with transgene-initiated low melanoma susceptibility.
Kelsall SR; Mintz B
Cancer Res; 1998 Sep; 58(18):4061-5. PubMed ID: 9751610
[TBL] [Abstract][Full Text] [Related]
7. Decline in MHC class I expression with increasing thickness of cutaneous melanomas in standard-strain transgenic mouse models.
Milling SW; Silvers WK; Sai T; Mintz B
Melanoma Res; 2002 Jun; 12(3):221-30. PubMed ID: 12140378
[TBL] [Abstract][Full Text] [Related]
8. Proliferation and morphology of melanoma cells and benign human melanocytes under varying culture conditions.
Eberle J; Krasagakis K; Garbe C; Orfanos CE
Melanoma Res; 1993 Apr; 3(2):107-12. PubMed ID: 8518548
[TBL] [Abstract][Full Text] [Related]
9. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
10. Tumors of the retinal pigment epithelium metastasize to inguinal lymph nodes and spleen in tyrosinase-related protein 1/SV40 T antigen transgenic mice.
Penna D; Schmidt A; Beermann F
Oncogene; 1998 Nov; 17(20):2601-7. PubMed ID: 9840923
[TBL] [Abstract][Full Text] [Related]
11. Immortalization and malignant transformation of hepatocytes by transforming genes of polyoma virus and of SV40 virus in vitro and in vivo.
Paul D; Höhne M; Hoffmann B
Klin Wochenschr; 1988; 66 Suppl 11():134-9. PubMed ID: 2846952
[TBL] [Abstract][Full Text] [Related]
12. Clonal coat color variation due to a transforming gene expressed in melanocytes of transgenic mice.
Bradl M; Larue L; Mintz B
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6447-51. PubMed ID: 1650469
[TBL] [Abstract][Full Text] [Related]
13. Changes in expression of putative antigens encoded by pigment genes in mouse melanomas at different stages of malignant progression.
Orlow SJ; Hearing VJ; Sakai C; Urabe K; Zhou BK; Silvers WK; Mintz B
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10152-6. PubMed ID: 7479744
[TBL] [Abstract][Full Text] [Related]
14. Haploid male germ cells show no susceptibility to transformation by simian virus 40 large tumour antigen in transgenic mice.
Nayernia K; Samani AA; Klaproth S; Engel W
Cell Biol Int; 1998; 22(6):437-43. PubMed ID: 10328852
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of human melanocytes: induction of a complete melanoma phenotype and genotype.
Albino AP; Sozzi G; Nanus DM; Jhanwar SC; Houghton AN
Oncogene; 1992 Nov; 7(11):2315-21. PubMed ID: 1437153
[TBL] [Abstract][Full Text] [Related]
16. Effects of MGSA/GRO alpha on melanocyte transformation.
Balentien E; Mufson BE; Shattuck RL; Derynck R; Richmond A
Oncogene; 1991 Jul; 6(7):1115-24. PubMed ID: 1861861
[TBL] [Abstract][Full Text] [Related]
17. Transgenic mouse model of malignant skin melanoma.
Mintz B; Silvers WK
Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8817-21. PubMed ID: 8415613
[TBL] [Abstract][Full Text] [Related]
18. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background.
Ackermann J; Frutschi M; Kaloulis K; McKee T; Trumpp A; Beermann F
Cancer Res; 2005 May; 65(10):4005-11. PubMed ID: 15899789
[TBL] [Abstract][Full Text] [Related]
19. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
20. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences.
March KL; Sandusky G; Fan L
Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
